Stock Research for ACUR

ACUR
Current Price

$0.6100


Latest Update: 2018-01-16 16:00:00

High
$ 0.6100
Low
$ 0.6100
Close
$ 0.6100
Volume
800
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ACUR Stock Chart & Research Data

The ACUR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACUR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACUR Due diligence Resources & Stock Charts

The ACUR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACUR Detailed Price Forecast - CNN Money CNN View ACUR Detailed Summary - Google Finance
Yahoo View ACUR Detailed Summary - Yahoo! Finance Zacks View ACUR Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ACUR Trends & Analysis - Trade-Ideas Barrons View ACUR Major Holders - Barrons
NASDAQ View ACUR Call Transcripts - NASDAQ Seeking View ACUR Breaking News & Analysis - Seeking Alpha
Spotlight View ACUR Annual Report - CompanySpotlight.com OTC Report View ACUR OTC Short Report - OTCShortReport.com
TradeKing View ACUR Fundamentals - TradeKing Charts View ACUR SEC Filings - Bar Chart
WSJ View Historical Prices for ACUR - The WSJ Morningstar View Performance/Total Return for ACUR - Morningstar
MarketWatch View the Analyst Estimates for ACUR - MarketWatch CNBC View the Earnings History for ACUR - CNBC
StockMarketWatch View the ACUR Earnings - StockMarketWatch MacroAxis View ACUR Buy or Sell Recommendations - MacroAxis
Bullish View the ACUR Bullish Patterns - American Bulls Short Pains View ACUR Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ACUR Stock Mentions - StockTwits PennyStocks View ACUR Stock Mentions - PennyStockTweets
Twitter View ACUR Stock Mentions - Twitter Invest Hub View ACUR Investment Forum News - Investor Hub
Yahoo View ACUR Stock Mentions - Yahoo! Message Board Seeking Alpha View ACUR Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ACUR - SECform4.com Insider Cow View Insider Transactions for ACUR - Insider Cow
CNBC View ACUR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACUR - OTC Markets
Yahoo View Insider Transactions for ACUR - Yahoo! Finance NASDAQ View Institutional Holdings for ACUR - NASDAQ


Stock Charts

FinViz View ACUR Stock Insight & Charts - FinViz.com StockCharts View ACUR Investment Charts - StockCharts.com
BarChart View ACUR Stock Overview & Charts - BarChart Trading View View ACUR User Generated Charts - Trading View


Latest Financial News for ACUR

Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301
Posted on Monday January 08, 2018

PALATINE, Ill., Jan. 08, 2018-- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from clinical study AP-LTX-301 for ...


Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
Posted on Monday December 25, 2017

Categories: Yahoo FinanceGet free summary analysis Acura Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Acura Pharmaceuticals, Inc. – Elite Pharmaceuticals, Inc., Rigel Pharmaceuticals, Inc., Innoviva, Inc., Aradigm Corporation, OPKO Health, Inc., Pfizer Inc., Nektar Therapeutics, Windtree Therapeutics, Inc. and Pain Therapeutics, Inc. ... Read more (Read more...)


Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results
Posted on Monday November 13, 2017

PALATINE, Ill., Nov. 13, 2017-- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine months ended September ...


ETFs with exposure to Acura Pharmaceuticals, Inc. : September 7, 2017
Posted on Thursday September 07, 2017

Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Acura Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACUR-US. Comparing the performance and risk of Acura Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)


Acura Pharmaceuticals Inc.
Wall Street Journal - Feb 13, 2011
P/E Ratio (TTM): The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period ...

Acura Pharmaceuticals Seeks To Raise $5 Million In Offering
Seeking Alpha - Feb 7, 2017
Acura Pharmaceuticals has filed to raise $5 million in a follow-on stock and warrant offering. The company is commercializing tamper-resistant medication technologies, but appears to be running out of money and time.

Acura Pharmaceuticals Advances LTX-03 and its LIMITx™ Technology
GlobeNewswire (press release) - Oct 9, 2017
PALATINE, Ill., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from clinical study AP-LTX-300 (Study 300) for its ...

Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed ...
GlobeNewswire (press release) - Mar 17, 2017
PALATINE, Ill., March 17, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR) and MainPointe Pharmaceuticals, LLC today announced that they have entered into a License Agreement (the "Agreement") to have MainPointe exclusively market ...

Enter a stock symbol to view the stock details.